MetaCap

BlossomHill Therapeutics (BLSM) vs Shattuck Labs (STTK)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.

Summary

Shattuck Labs is the larger company by market cap ($567.6 million vs $527.9 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BLSM+3.81%STTK-22.21%
+72%+23%-27%
Aug 7, 20261 yearOct 7, 2026
BLSM+3.81%STTK-22.21%
+65%+19%-26%
Aug 3, 20265 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BLSM versus STTK key metrics
MetricBLSMSTTK
Share price$16.61$5.66
Market cap$527.95M$567.55M
1-day change-3.93%-3.50%
YTD return—+54.93%
1-year return—+130.82%
5-year return—-70.74%
EPS (TTM)$-4.70$-0.47
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$27.99$8.33
52-week low$15.25$1.70
Distance from 52-week high-40.66%-32.11%
Average volume263.69K1.20M
Shares outstanding31.78M100.36M
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

BLSM vs STTK FAQ

Which is bigger, BlossomHill Therapeutics or Shattuck Labs?

Shattuck Labs (STTK) is larger, with a market capitalization of $567.55M compared with $527.95M for BlossomHill Therapeutics (BLSM).

Are BlossomHill Therapeutics and Shattuck Labs in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons